Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

NCT02102204 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

902

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperparathyroidism, Secondary

Interventions

DRUG: Etelcalcetide

Sponsor

Amgen